Reading time: 5 minutes Patty Spears The applause was thunderous and traveled like a wave across the large auditorium at the end of a 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session talk. It did not stop. The audience stood and kept applauding and reveling in the positive results of a clinical... Continue Reading →
Addressing racial and ethnic disparity in cancer research
Reading time: 5 minutes Aileen I Fernandez Cancer is a complex disease associated with multiple factors. To fully understand the disease and find treatments, these multiple factors should be addressed. One of the intractable layers associated with this disease is the health disparity. The disparity here refers to a greater disease burden seen in one... Continue Reading →
Cisplatin: a journey to a solution for triple-negative breast cancer
Tushar Date Estimated Reading time: 4 minutes Cisplatin is an old, platinum based anticancer drug that kills cancer cells by damaging their DNA. Its cytotoxic (cell-killing) properties were discovered by accident in the 1960s, when Barnett Rosenberg was performing experiments to analyse the effect of electric field on bacterial growth. He observed that bacterial proliferation... Continue Reading →
Understanding the heterogeneity of triple-negative breast cancer to develop targeted therapies
Reading time: 3 minutes Aishwarya Subramanian Breast cancer has shown to be a really aggressive condition. About 12% of the women in the US are known to develop invasive breast cancer, where the disease spreads into surrounding healthy tissues [a]. Now it is well established that breast cancer is a very heterogeneous disease. Genome studies... Continue Reading →
Searching for the Switch: How Cancer Cells Become Drug-Resistant
Reading time: 4 minutes Sara Musetti Picture this: You walk into a strange room. Maybe you’re at a friend’s house, or the restroom in a new coffee shop, or a hotel room. It’s dark, and you can’t see, but no matter where you put your hand, you just can’t find the light switch. You know... Continue Reading →
Estrogen on the Brain: How Hormones Might Be Increasing Brain Metastasis
Reading time: 3 minutes Sara Musetti One of the realities of cancer is that the primary tumor is rarely the cause of issues; usually, mortality and complications come from tumor cells spreading throughout the body and forming new tumors, a process called metastasis. For most cancers, the primary tumor can be surgically removed, but once... Continue Reading →
Engineering aggressive breast cancer subtype may allow more treatment choices
Manisit Das Breast cancer may sound like a single disease, but it is not. There are many subtypes of the disease, which guide the course of disease progression and treatment strategy. One of these subtypes, referred to as triple-negative breast cancer (TNBC) is particularly difficult to treat. Recently, researchers at Lund University, Sweden identified a... Continue Reading →